Poultry Vaccination - Photo Credit OIE
#19,327
Nearly 14 years ago, in Egypt: A Paltry Poultry Vaccine, we looked at an analysis by the researchers from the Virology department at St. Jude Children’s Research Hospital - that studied the effectiveness of six commercially available H5 poultry vaccines then deployed in Egypt.
They reported - out of the 6 vaccines tested - only one (based on a locally acquired H5N1 seed virus) actually appeared to offer genuine protection.
This was at a time when H5 vaccination was only utilized by a handful of countries (primarily China, Indonesia, Egypt, and Vietnam), and the OIE (now WOAH) routinely warned that vaccination of poultry `. . . cannot be considered a long-term solution to combating the avian flu virus'.
The authors of this study urged:
In light of our findings, we recommend that the H5N1 prevention and control strategy in Egypt be updated and reinforced. Special consideration should be given to the vaccination strategy, and the use of vaccines based on currently circulating viruses is advisable.
Fast-forward 6 years (2018) and the St. Jude research team revisited Egypt's poultry vaccination program (see Sci. Reports: Efficacy Of AI Vaccines Against The H5N8 Virus in Egypt), and found many of the same problems persisted.
They wrote:
Our results indicate that most of the commercial poultry H5 vaccines used in the present study were ineffective because the seed viruses in these vaccines are genetically distinct from the H5N8 viruses currently circulating in Egypt.
Although some of the commercial vaccines protected chickens from mortality, they failed to prevent chickens from shedding the virus. Accordingly, we recommend updating and reinforcing the H5N8 prevention and control strategies in Egypt. The vaccination strategy should be reconsidered based on currently circulating viruses.
While the reduced mortality among poultry may have seemed like a `win' for farmers, theses avian flu viruses could continue to spread - often unnoticed - due to the `masking' of symptoms by the vaccine.
Of course, Egypt wasn't alone in the continued use of older, mismatched, poultry vaccines. Earlier in 2018, in PLoS One: Effectiveness of HPAI H5N1 Vaccination in Poultry - Indonesia, we looked at an assessment of that country's poultry vaccination campaign.
HPAI vaccination, intensively applied in Sector 3 layers in Indonesia, had highly variable outcome, including vaccination failures and did not provide sufficiently long protective immunity in the majority of flocks. Indonesia adopted HPAI vaccination in 2004 with the aim of reducing the incidence of H5N1 infections in poultry, with the ultimate objective of achieving eradication of the virus.
The concern is that vaccine mismatches, and/or poor or inconsistent application, can allow avian flu to spread silently among flocks, and may allow AI viruses to continue to reassort and evolve, potentially leading to the emergence of new variants of avian flu.
A few earlier blogs addressing those concerns include:
Subclinical Highly Pathogenic Avian Influenza Virus Infection among Vaccinated Chickens, China.
Study: Recombinant H5N2 Avian Influenza Virus Strains In Vaccinated Chickens
EID Journal: Subclinical HPAI In Vaccinated Poultry – China
While there have certainly been successful avian flu vaccination campaigns (see EID Journal: China's H5+H7 Poultry Vaccination Program, Guangdong 2017-18), vaccines must be continually updated - and flocks tested for breakthrough infections - in order to remain successful.
In 2025, in NPJ Vaccines: Impact of Inactivated Vaccine on Transmission and Evolution of H9N2 Avian Influenza Virus in Chickens, we saw evidence that not only had inactivated vaccines failed to prevent - or even reduce - LPAI H9N2 in China's poultry, they may have driven viral evolution (including mammalian adaptations).
None of this is to suggest that an effective poultry vaccine campaign can't be mounted, or effectively maintained. But it does require more than just a `vaccinate & forget' strategy.
All of which brings us to a new study which finds that despite the introduction of newer vaccine formulations, many of the earlier concerns about Egypt's vaccination program persist. I've only posted the Abstract, and some excerpts, so follow the link to read it in its entirety.
I'll have a bit more after the break.
Research
Open access
Published: 08 September 2026
Volume 3, article number 22 (2026)
Download PDF
Ahmed El Taweel, Mokhtar Gomaa, Yassmin Moatasim, Omnia Kutkat, Mina Nabil Kamel, Mohamed El Sayes, Mohamed GabAllah, Mohamed Ahmed Ali, Ghazi Kayali & Rabeh El-Shesheny
Abstract
Background
Avian influenza viruses (AIVs) continue to cause substantial economic losses to the poultry industry and pose a significant burden on global public health systems. The increasing diversity and geographical spread of different subtypes of influenza viruses in poultry populations increases the risk for reassortment events and the emergence of novel strains. Vaccination remains a key strategy for preventing influenza infection and its complications, especially high pathogenic avian influenza (HPAI), as it can reduce morbidity, mortality, and viral transmission.However, vaccine effectiveness is closely tied to the antigenic match between vaccine strains and circulating viruses. In this study, we tested six commonly used commercial poultry H5 vaccines in Egypt to evaluate mortality, and virus shedding following experimental infection of specific pathogen free chickens with clade 2.3.4·4b H5N1 and H5N8 HPAI viruses.
Results
Our results showed that most of the tested vaccines provided detectable antibody titers and protected against mortality but were not able to control virus shedding. ValleyVac vaccines induced high HI titers (up to 9 log2) against recent clade 2.3.4·4b A(H5N1) and A(H5N8) strains, while Zoetis and Egy-flu R 2-in-1 induced lower HI titers (<6 log2). Although some of the commercial vaccines did not elicit considerable HI titers, vaccines provided 71%–100% protection against clade 2.3.4·4b viruses. Importantly, virus titers were detected till seven days post-infection (dpi). This incomplete protection is likely due to genetic and antigenic mismatches between the vaccine seed strains and the H5N1 and H5N8 viruses detected in Egypt.
ConclusionsThese results highlight the urgent need to revise H5Nx prevention and control strategies in Egypt and update vaccine seed strains to reflect currently circulating HPAI viruses.
(SNIP)
The prolonged use of suboptimal vaccines or inadequate vaccination programs may contribute to the selection of antigenic escape mutants through immune pressure, potentially reducing vaccine effectiveness.
In summary, our data indicate that vaccines designed on strains that differ from circulating strains are not able to provide optimal protection. Although an immune response was elicited and survival rates were high, viral shedding continued. This indicates that the use of those vaccines will reduce morbidity and mortality but will allow virus transmission and potentially the emergence of vaccine escape mutants.
Mass vaccination remains a crucial component of a multifaceted approach aimed at preventing AIV illness and its spread in poultry. The ongoing threat of an AIV pandemic highlights the need to design novel vaccines that are easier to manufacture, more streamlined, and capable of inducing better and broader immune protection against emerging strains.
But as HPAI increases its presence in the environment - and continues to spill over into livestock - the need for well mounted vaccination campaigns only increases.
We've discussed some of the ongoing biosecurity measures that would be required to mount a safe and effective poultry vaccination campaign (see UK Joint Taskforce Policy Paper: Vaccination of Birds Against HPAIV (bird flu)), including:
- Most captive birds would likely require more than one vaccination over their lifetime, and regular testing that can differentiate infected from vaccinated animals (DIVA) would be needed to prevent `subclinical spread' of the virus.
- Culling and/or quarantine would still be needed for `breakthrough' infections
- A different vaccine, schedule and testing regimen would likely be required for non-avian livestock.
- And vaccine seed viruses would have to be regularly updated to match circulating strains
But only if we take the time and effort to do it right.


